Published :
Tables : 140
Figures : 42
Category : Healthcare
No. of Pages : 200
Report Code : HC-1262
Digital Diabetes Management Market is estimated to value over USD 20 billion by 2027 end and register a CAGR of over 22.5% during the forecast period 2020 to 2027. Diabetes is quite prevalent across the world. As per the International Diabetes Federation (IDF), diabetes has influenced around 430 million people worldwide. In that sense, several organizations of digital health have acknowledged a chance to enable patients to control and oversee their illness. Digital diabetes management market is proliferated by expanding diabetes pervasiveness amongst patients of different age groups across the world. Problems like restricted management and learning and diabetes management amongst major partners give rise to extreme sufferings to patients and increase the cost of the treatment which prompts the guardian and parents to use digital management of diabetes that makes the diabetes management market obtain immense popularity in the upcoming years. Similarly, expanding web entrance in developed and developing nations, increased adult diabetic population who react to industrial advancements is projected to aid the development of income for the market in the upcoming years. However, an absence of fundamental innovation, web access and framework in emerging nations is projected to significantly impact the income development of the market over the forecast period. Key market players of the market industry include Medtronic Plc, Dexcom Inc., F.Hoffmann-La Roche, Abbott Laboratories, Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Tidepool, Glooko Inc., Lifescan Inc., Agamatrix Inc., tandem Diabetes Care Inc., Insulet Corp., Dariohealth Corp. Digital Diabetes Management Market Segmentation: By Product & Service • Devices o Smart Glucose Meters o Continuous Glucose Monitoring Systems o Smart Insulin Pens o Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches • Digital Diabetes Management Apps o Diabetes & Blood Glucose Tracking Apps o Weight & Diet Management Apps • Data Management Software and Platforms • Services By Type • Wearable Devices • Handheld Devices By End User • Self/Home Healthcare • Hospitals & Specialty Diabetes Clinics • Academic & Research Institutes By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global digital diabetes management market by product & service, by type, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Diabetes is quite prevalent across the world. As per the International Diabetes Federation (IDF), diabetes has influenced around 430 million people worldwide. In that sense, several organizations of digital health have acknowledged a chance to enable patients to control and oversee their illness.
Digital diabetes management market is proliferated by expanding diabetes pervasiveness amongst patients of different age groups across the world. Problems like restricted management and learning and diabetes management amongst major partners give rise to extreme sufferings to patients and increase the cost of the treatment which prompts the guardian and parents to use digital management of diabetes that makes the diabetes management market obtain immense popularity in the upcoming years.
Similarly, expanding web entrance in developed and developing nations, increased adult diabetic population who react to industrial advancements is projected to aid the development of income for the market in the upcoming years. However, an absence of fundamental innovation, web access and framework in emerging nations is projected to significantly impact the income development of the market over the forecast period.
Key market players of the market industry include Medtronic Plc, Dexcom Inc., F.Hoffmann-La Roche, Abbott Laboratories, Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Tidepool, Glooko Inc., Lifescan Inc., Agamatrix Inc., tandem Diabetes Care Inc., Insulet Corp., Dariohealth Corp.
Digital Diabetes Management Market Segmentation:
By Product & Service • Devices o Smart Glucose Meters o Continuous Glucose Monitoring Systems o Smart Insulin Pens o Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches • Digital Diabetes Management Apps o Diabetes & Blood Glucose Tracking Apps o Weight & Diet Management Apps • Data Management Software and Platforms • Services
By Type • Wearable Devices • Handheld Devices
By End User • Self/Home Healthcare • Hospitals & Specialty Diabetes Clinics • Academic & Research Institutes
By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Digital Diabetes Management Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Global Digital Diabetes Management Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Digital Diabetes Management Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Digital Diabetes Management Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals and Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Digital Diabetes Management Market, By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Devices 7.1.1. Smart Glucose Meters 7.1.1. Continuous Glucose Monitoring Systems 7.1.1. Smart Insulin Pens 7.1.1. Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches 7.2. Digital Diabetes Management Apps 7.2.1. Diabetes & Blood Glucose Tracking Apps 7.2.2. Weight & Diet Management Apps 7.3. Data Management Software and Platforms 7.4. Services 8. Global Digital Diabetes Management Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Disposable Digital Diabetes Management 8.2. Handheld Devices 9. Global Digital Diabetes Management Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Self/Home Healthcare 9.2. Hospitals & Specialty Diabetes Clinics 9.3. Academic & Research Institutes 10. North America Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Medtronic Plc 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Dexcom Inc. 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. F.Hoffmann-La Roche 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Abbott Laboratories 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Ascensia Diabetes Care Holdings Ag 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. B. Braun Melsungen AG 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Tidepool 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Glooko Inc. 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Lifescan Inc. 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Agamatrix Inc. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Tandem Diabetes Care Inc. 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Insulet Corp. 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Dariohealth Corp. 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 16. Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global Digital Diabetes Management Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards And Compliances
5. Global Digital Diabetes Management Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus of Digital Diabetes Management Companies on Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Digital Diabetes Management Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals and Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global Digital Diabetes Management Market, By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Devices
7.1.1. Smart Glucose Meters
7.1.1. Continuous Glucose Monitoring Systems
7.1.1. Smart Insulin Pens
7.1.1. Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches
7.2. Digital Diabetes Management Apps
7.2.1. Diabetes & Blood Glucose Tracking Apps
7.2.2. Weight & Diet Management Apps
7.3. Data Management Software and Platforms
7.4. Services
8. Global Digital Diabetes Management Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Disposable Digital Diabetes Management
8.2. Handheld Devices
9. Global Digital Diabetes Management Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Self/Home Healthcare
9.2. Hospitals & Specialty Diabetes Clinics
9.3. Academic & Research Institutes
10. North America Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
10.2.1. U.S.A
10.2.2. Canada
10.2.3. Mexico
10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Latin America Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.3.1. Brazil
11.3.2. Venezuela
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Market Size (USD Million) Forecast for Latin America 2020-2027
12. Europe Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Germany
12.2.2. U.K
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Russia
12.2.7. Poland
12.2.8. Switzerland
12.2.9. Rest of Western Europe
12.3. Market Size (USD Million) Forecast for Europe 2020-2027
13. Asia Pacific Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Japan
13.2.2. China
13.2.3. Singapore
13.2.4. India
13.2.5. Australia and New Zealand
13.2.6. ASEAN
13.2.7. South Korea
13.2.8. Taiwan
13.2.9. Rest of Asia Pacific
13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Digital Diabetes Management Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Saudi Arabia
14.2.2. UAE
14.2.3. South Africa
14.2.4. Egypt
14.3. Market Size (USD Million) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
15.1. Medtronic Plc
15.1.1. Company Overview
15.1.2. Product Portfolio
15.1.3. SWOT Analysis
15.1.4. Financial Overview
15.1.5. Strategic Overview
15.2. Dexcom Inc.
15.2.1. Company Overview
15.2.2. Product Portfolio
15.2.3. SWOT Analysis
15.2.4. Financial Overview
15.2.5. Strategic Overview
15.3. F.Hoffmann-La Roche
15.3.1. Company Overview
15.3.2. Product Portfolio
15.3.3. SWOT Analysis
15.3.4. Financial Overview
15.3.5. Strategic Overview
15.4. Abbott Laboratories
15.4.1. Company Overview
15.4.2. Product Portfolio
15.4.3. SWOT Analysis
15.4.4. Financial Overview
15.4.5. Strategic Overview
15.5 Ascensia Diabetes Care Holdings Ag
15.5.1. Company Overview
15.5.2. Product Portfolio
15.5.3. SWOT Analysis
15.5.4. Financial Overview
15.5.5. Strategic Overview
15.6. B. Braun Melsungen AG
15.6.1. Company Overview
15.6.2. Product Portfolio
15.6.3. SWOT Analysis
15.6.4. Financial Overview
15.6.5. Strategic Overview
15.7. Tidepool
15.7.1. Company Overview
15.7.2. Product Portfolio
15.7.3. SWOT Analysis
15.7.4. Financial Overview
15.7.5. Strategic Overview
15.8. Glooko Inc.
15.8.1. Company Overview
15.8.2. Product Portfolio
15.8.3. SWOT Analysis
15.8.4. Financial Overview
15.8.5. Strategic Overview
15.9. Lifescan Inc.
15.9.1. Company Overview
15.9.2. Product Portfolio
15.9.3. SWOT Analysis
15.9.4. Financial Overview
15.9.5. Strategic Overview
15.10. Agamatrix Inc.
15.10.1. Company Overview
15.10.2. Product Portfolio
15.10.3. SWOT Analysis
15.10.4. Financial Overview
15.10.5. Strategic Overview
15.11. Tandem Diabetes Care Inc.
15.11.1. Company Overview
15.11.2. Product Portfolio
15.11.3. SWOT Analysis
15.11.4. Financial Overview
15.11.5. Strategic Overview
15.12. Insulet Corp.
15.12.1. Company Overview
15.12.2. Product Portfolio
15.12.3. SWOT Analysis
15.12.4. Financial Overview
15.12.5. Strategic Overview
15.13. Dariohealth Corp.
15.13.1. Company Overview
15.13.2. Product Portfolio
15.13.3. SWOT Analysis
15.13.4. Financial Overview
15.13.5. Strategic Overview
16. Impact of COVID-19
16.1. Positive influence on the healthcare industry
16.2. The financial disruption of the manufacturing sector
16.3. Impact of COVID-19 on emerging companies
16.4. Significant mandates in the healthcare regulations initiated by administrations
16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics